Clinical characteristics of Japanese patients with moderate to severe COVID-19

INTRODUCTION: Although several reports on the risk factors for severe disease of COVID-19 already exist, reports on effective early indicators are still limited, especially from Japan. This study was conducted to clarify the patient’s characteristics whose disease progressed to severe status. METHOD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Chemother
Autors principals: Otoshi, Ryota, Hagiwara, Eri, Kitayama, Takaaki, Yamaya, Takafumi, Higa, Katsuyuki, Murohashi, Kota, Sato, Yozo, Tabata, Erina, Shintani, Ryota, Okabayashi, Hiroko, Ikeda, Satoshi, Niwa, Takashi, Nakazawa, Atsuhito, Oda, Tsuneyuki, Okuda, Ryo, Sekine, Akiamasa, Kitamura, Hideya, Baba, Tomohisa, Komatsu, Shigeru, Ogura, Takashi
Format: Artigo
Idioma:Inglês
Publicat: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931728/
https://ncbi.nlm.nih.gov/pubmed/33727024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2021.02.028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars